Education
About Us
Working with TipRanks
Follow Us
Vitalhub (TSE:VHI)
TSX:VHI
VHI Stock Chart & Stats
C$7.87
-C$0.14(-1.23%)
At close: 4:00 PM EST
C$7.87
-C$0.14(-1.23%)
Day’s Range― - ―
52-Week RangeC$7.63 - C$14.64
Previous CloseN/A
Volume94.87K
Average Volume (3M)148.97K
Market Cap
C$509.65M
Enterprise ValueC$377.84M
Total Cash (Recent Filing)C$123.68M
Total Debt (Recent Filing)C$1.60M
Price to Earnings (P/E)154.5
Beta0.56
Next Earnings
Mar 12, 2026EPS Estimate
0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding63,232,063
10 Day Avg. Volume164,389
30 Day Avg. Volume148,972
Financial Highlights & Ratios
PEG Ratio-4.74
Price to Book (P/B)3.83
Price to Sales (P/S)8.08
P/FCF Ratio38.93
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$12.50Price Target Upside58.83% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Recurring Revenue / ARRA large, growing ARR base with 74% recurring revenue increases revenue predictability and customer stickiness. Organic ARR growth plus acquisition-driven expansion supports durable revenue visibility, enabling multi-year planning, predictable cash flows and higher lifetime customer value.
High Gross MarginsSustained ~81% gross margins reflect a software-focused business with scalable unit economics. High gross margins provide structural leverage as revenue scales, enabling investment in R&D and integration while preserving profitability even when SG&A rises during growth or M&A cycles.
Strong Balance Sheet & LiquidityVery strong liquidity and negligible leverage provide strategic optionality for further acquisitions, product investment, and absorbing public-sector sales cycles. A high equity ratio and large cash buffer materially reduce refinancing and solvency risk during multi-quarter integration periods.
Bears Say
Weak Cash ConversionLow cash conversion (OCF/net income 0.19) and declining free cash flow growth indicate earnings are not fully translating into cash. That constrains internally funded expansion, raises reliance on the cash balance for acquisitions, and necessitates working-capital discipline to sustain long-term investment.
Declining EBITDA MarginA meaningful drop in adjusted EBITDA margin signals margin pressure from integration costs, pricing, or higher operating spend. If persistent, lower operational leverage will reduce free cash generation and hamper the company's ability to fund growth or absorb cyclical public-sector delays without margin recovery.
Product & Market HeadwindsStructural challenges in key markets (NHS changes) and underperforming products (Strata, Attend Anywhere facing strong incumbents) create persistent revenue risk in public-sector accounts. Addressing these requires product repositioning and sales changes, which can take multiple quarters to stabilize growth.
Vitalhub News
VHI FAQ
What was Vitalhub’s price range in the past 12 months?
Vitalhub lowest stock price was C$7.63 and its highest was C$14.64 in the past 12 months.
What is Vitalhub’s market cap?
Vitalhub’s market cap is C$509.65M.
When is Vitalhub’s upcoming earnings report date?
Vitalhub’s upcoming earnings report date is Mar 12, 2026 which is in 15 days.
How were Vitalhub’s earnings last quarter?
Vitalhub released its earnings results on Nov 06, 2025. The company reported -C$0.01 earnings per share for the quarter, missing the consensus estimate of C$0.037 by -C$0.047.
Is Vitalhub overvalued?
According to Wall Street analysts Vitalhub’s price is currently Undervalued.
Does Vitalhub pay dividends?
Vitalhub does not currently pay dividends.
What is Vitalhub’s EPS estimate?
Vitalhub’s EPS estimate is 0.05.
How many shares outstanding does Vitalhub have?
Vitalhub has 63,232,063 shares outstanding.
What happened to Vitalhub’s price movement after its last earnings report?
Vitalhub reported an EPS of -C$0.01 in its last earnings report, missing expectations of C$0.037. Following the earnings report the stock price went up 2.92%.
Which hedge fund is a major shareholder of Vitalhub?
Currently, no hedge funds are holding shares in TSE:VHI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Vitalhub Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
C$12.50 (58.83% Upside)
C$12.50 (58.83% Upside)
Blogger Sentiment
Bullish
TSE:VHI Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth C$1.4M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.9%
Last 30 Days ▼ 13.2%
Last 30 Days ▼ 13.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
7.33%
12-Months-Change
Fundamentals
Return on Equity
1.45%
Trailing 12-Months
Asset Growth
56.92%
Trailing 12-Months
Company Description
Vitalhub
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination, patient flow and operational visibility, and mobile apps. The company was incorporated in 2010 and is based in Toronto, Canada.
VHI Stock 12 Month Forecast
Average Price Target
C$12.50
▲(58.83% Upside)
Technical Analysis
Diagnos
―
kneat.com
―
nDatalyze Corp
―
Comprehensive Healthcare Systems Inc
―
UniDoc Health Corp
―
Options Prices
Currently, No data available
---